XML 57 R44.htm IDEA: XBRL DOCUMENT v3.22.0.1
IMPAIRMENT OF LONG-LIVED AND OTHER ASSETS (Tables)
12 Months Ended
Dec. 31, 2021
Impairment or Disposal of Tangible Assets Disclosure [Abstract]  
Summary of Long Lived Asset Impairment Evaluations Performed by Assets Classification The following table is a summary of the evaluations performed for each quarter by asset classification.

 

Asset

 

Impairment

 

Valuation

 

Valuation

 

Category

 

Test

 

Approach

 

Multiple

First and second quarters

 

 

 

 

 

 

 

Goodwill

 

Qualitative

 

N/A

 

N/A

 

Tradename intangible assets

 

Qualitative

 

N/A

 

N/A

 

Other long-lived assets

 

Qualitative

 

N/A

 

N/A

 

 

 

 

 

 

 

 

Third quarter

 

 

 

 

 

 

 

Goodwill

 

Qualitative

 

N/A

 

N/A

 

Tradename intangible assets

 

Qualitative

 

N/A

 

N/A

 

Other long-lived assets

 

Quantitative

 

Market

 

3.1 to 6 times

 

 

 

 

 

 

 

 

Fourth quarter

 

 

 

 

 

 

 

Goodwill

 

Quantitative

 

Market

 

3.7 to 7 times

 

Tradename intangible assets

 

Quantitative

 

Income

 

N/A

 

Other long-lived assets

 

Quantitative

 

Market

 

3.7 to 6 times

Long-Lived Asset Impairment Losses

The Company’s impairment charges were as follows for the periods indicated:

 

 

Year Ended

 

 

December 31,

 

 

2019

 

2020

 

2021

U.S. segment

 

 

 

 

 

 

Theatre properties

 

$36,005

 

$12,398

 

$6,371

Theatre operating lease right-of-use assets

 

10,457

 

13,216

 

6,804

Investment in NCM (1)

 

 

92,655

 

Cost method investment

 

 

2,500

 

U.S. total

 

46,462

 

120,769

 

13,175

 

 

 

 

 

 

 

International segment

 

 

 

 

 

 

Theatre properties

 

8,821

 

9,951

 

4,002

Theatre operating lease right-of-use assets

 

1,718

 

5,025

 

3,210

Goodwill

 

 

16,128

 

Intangible assets, net

 

 

833

 

458

International total

 

10,539

 

31,937

 

7,670

 

 

 

 

 

 

 

Total impairment

 

$57,001

 

$152,706

 

$20,845

(1)
See Note 8 for discussion of investment in NCM.